Ernexa Therapeutics ERNAW Growth Metrics (2010-2026)

NASDAQ ERNAW
$0.06 +0.01 (+25.27%)
As of: Sep 4, 2026 · 3:55 PM EDT
Reported Financials

Ernexa Therapeutics Quarterly Growth Metrics

Periods 64 quarters
Latest Jun 2026

Ernexa Therapeutics growth metrics data for the quarter ended Jun 2026. These growth metrics cover 64 quarters of results from Sep 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth Metrics Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Dividend Coverage Ratio Growth (1y)Div. Cover Growth (1y)
Dividend Coverage Ratio Growth (3y)Div. Cover Growth (3y)
Dividend Coverage Ratio Growth (5y)Div. Cover Growth (5y)
EBITDA Margin Growth (1y)
1.03M-0.24M
EBITDA Margin Growth (3y)
-1.07M-1.16M
EBITDA Margin Growth (5y)
-1.08M-1.18M-1.23M-1.05M-0.05M-1.42M
EBITDA Margin (QoQ)
-0.10M-0.05M0.18M1.00M-1.37M
EBIT Margin Growth (1y)
1.03M-0.24M
EBIT Margin Growth (3y)
-1.07M-1.16M
EBIT Margin Growth (5y)
-1.08M-1.18M-1.23M-1.05M-0.05M-1.42M
EBIT Margin (QoQ)
-0.10M-0.05M0.18M1.00M-1.37M
EBT Margin Growth (1y)
0.55M-1.78M
EBT Margin Growth (3y)
-1.09M-1.23M
EBT Margin Growth (5y)
-1.10M-1.26M-1.41M-1.18M-0.55M-3.03M
EBT Margin (QoQ)
-0.16M-0.16M0.24M0.63M-2.49M
FCF Margin Growth (1y)
1.49M-1.72M
FCF Margin Growth (3y)
-1.60M-0.14M
FCF Margin Growth (5y)
-1.62M-0.15M-0.82M-0.53M-0.13M-1.87M
FCF Margin (QoQ)
1.47M-0.67M0.29M0.40M-1.74M
FCF Payout Ratio Growth (1y)FCF Cover Growth (1y)
FCF Payout Ratio Growth (3y)FCF Cover Growth (3y)
FCF Payout Ratio Growth (5y)FCF Cover Growth (5y)
Gross Margin Growth (1y)
0.02M0.01M
Gross Margin Growth (3y)
-0.02M-0.01M
Gross Margin Growth (5y)
-0.02M-0.02M-0.01M-0.02M0.00M-0.00M
Gross Margin (QoQ)
0.00M0.01M-0.01M0.02M-0.01M
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y)
-614.75%98.21%94.18%-664.30%
Interest Coverage Ratio Growth (3y)Interest Cover Growth (3y)
49.95%
Interest Coverage Ratio (QoQ)Interest Cover (QoQ)
16.24%100.50%-171.75%51.27%
Net Margin Growth (1y)
0.55M-1.78M
Net Margin Growth (3y)
-1.08M-1.24M
Net Margin Growth (5y)
-1.10M-1.26M-1.41M-1.18M-0.55M-3.03M
Net Margin (QoQ)
-0.16M-0.16M0.24M0.63M-2.49M
Operating Margin Growth (1y)
1.03M-0.24M
Operating Margin Growth (3y)
-1.07M-1.16M
Operating Margin Growth (5y)
-1.08M-1.18M-1.23M-1.05M-0.05M-1.42M
Operating Margin (QoQ)
-0.10M-0.05M0.18M1.00M-1.37M
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
-0.03M-0.02M-0.03M0.01M0.02M0.02M0.03M0.01M0.01M0.01M0.00M-0.01M-0.06M-0.08M-0.06M-0.01M0.05M0.08M0.05M
Return on Assets [ROA] Growth (3y)ROA Growth (3y)
-0.03M-0.03M-0.01M-0.01M-0.01M0.00M0.01M0.00M0.01M-0.03M-0.05M-0.03M-0.01M-0.01M-0.00M-0.01M
Return on Assets [ROA] Growth (5y)ROA Growth (5y)
-0.02M-0.03M-0.03M-0.03M-0.01M-0.01M-0.01M-0.01M-0.00M-0.00M-0.02M-0.07M-0.09M-0.02M738.00-0.01M
Return on Assets [ROA] (QoQ)ROA (QoQ)
-0.01M-0.01M622.00-418.000.02M0.00M347.000.00M0.00M-242.00-361.00-340.00-0.01M-0.05M-0.02M0.02M0.04M0.00M0.01M-635.00
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y)
-0.02M-0.03M-0.04M120.000.01M0.01M0.04M0.02M0.02M0.02M0.00M-0.01M-0.04M0.03M-0.02M-0.01M0.01M-0.05M0.00M
Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y)
-0.04M-0.05M-0.02M-0.02M-0.02M0.01M0.01M895.000.01M-0.01M0.06M0.02M0.00M-0.01M-0.00M-0.02M
Return on Capital Employed [ROCE] Growth (5y)ROCE Growth (5y)
-0.02M-0.03M-0.03M-0.05M-0.02M-0.02M-0.02M-0.01M-0.01M-0.01M-0.01M-0.04M0.03M-0.02M-0.01M-0.02M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ)
-0.02M-0.01M-0.00M-0.01M0.03M-0.00M-447.000.01M0.00M239.00-400.00-525.00-0.01M-0.03M0.07M-0.05M0.01M-0.01M0.01M668.00
Return on Invested Capital [ROIC] Growth (1y)ROIC Growth (1y)
-0.03M-0.04M-0.15M
Return on Invested Capital [ROIC] Growth (3y)ROIC Growth (3y)
-0.02M-0.04M-0.02M0.05M32.00
Return on Invested Capital [ROIC] Growth (5y)ROIC Growth (5y)
-0.02M-0.04M-0.03M0.01M0.13M-0.02M-0.01M
Return on Invested Capital [ROIC] (QoQ)ROIC (QoQ)
-0.01M0.12M-0.39M0.24M-0.01M0.00M
Return on Sales [ROS] Growth (1y)ROS Growth (1y)
-1.01M-1.05M-0.96M1.03M-0.24M
Return on Sales [ROS] Growth (3y)ROS Growth (3y)
-0.07M-0.12M-0.27M-1.07M-1.16M
Return on Sales [ROS] Growth (5y)ROS Growth (5y)
-0.07M-0.12M-0.27M-1.08M-1.18M-1.23M-1.05M-0.05M-1.42M
Return on Sales [ROS] (QoQ)ROS (QoQ)
-0.05M-0.15M-0.10M-0.05M0.18M1.00M-1.37M